19:37:41 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Lion Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm

2017-05-16 12:00 ET - News Release


IRVINE, Calif. -- (Business Wire)

Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (Nasdaq: LBIO) concerning possible violations of federal securities laws.

If you purchased shares of Lion and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

The investigation focuses on whether Lion and certain of its officers and/or directors violated federal securities laws. On April 10, 2017, the Securities & Exchange Commission found that between September 2013 and March 2014, the Company’s former CEO, Manish Singh, misled investors by commissioning over 10 internet publications and 20 widely distributed emails promoting Lion to potential investors that purported to be independent from the company when they were actually paid promotions.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts:

Khang & Khang LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

Source: Khang & Khang LLP

© 2024 Canjex Publishing Ltd. All rights reserved.